The article reports concerns about the use of artificial intelligence to design viruses intended to kill antibiotic-resistant bacteria. Supporters say these engineered bacteriophages could offer a new treatment against infections that no longer respond to antibiotics, while critics warn that the same methods may lower barriers to creating harmful biological agents.

The debate centres on whether safety controls and oversight can keep pace with rapidly improving AI tools for designing genetic material. Although the work is presented as a potential response to antimicrobial resistance, experts cited in the article argue that its dual-use nature means accidental release, misuse or deliberate weaponisation must be considered.